Income Statement (TTM)
Gulf Pharmaceutical Industries P.S.C. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 540 | 573 | 632 | 682 | 858 | 1,143 | 1,398 | 1,598 | 1,651 | 1,616 | 1,652 | 1,637 | 1,587 | 1,278 | 1,160 | 1,094 | 1,145 | 1,312 | 1,335 | 1,344 |
| Change (%) | 6.13 | 10.31 | 7.96 | 25.78 | 33.19 | 22.31 | 14.30 | 3.32 | -2.13 | 2.20 | -0.88 | -3.04 | -19.51 | -9.18 | -5.71 | 4.67 | 14.63 | 1.71 | 0.68 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 360 | 388 | 414 | 435 | 600 | 760 | 931 | 1,093 | 1,109 | 1,058 | 1,072 | 1,076 | 1,023 | 852 | 744 | 682 | 712 | 793 | 806 | 791 |
| Change (%) | 7.63 | 6.86 | 4.85 | 38.13 | 26.57 | 22.48 | 17.43 | 1.51 | -4.61 | 1.31 | 0.40 | -4.97 | -16.67 | -12.73 | -8.37 | 4.43 | 11.46 | 1.63 | -1.87 | |
| % of Revenue | 66.75 | 67.70 | 65.58 | 63.69 | 69.94 | 66.46 | 66.55 | 68.38 | 67.18 | 65.48 | 64.91 | 65.75 | 64.45 | 66.72 | 64.12 | 62.31 | 62.17 | 60.45 | 60.40 | 58.87 |
| Gross Operating Profit | 180 | 185 | 218 | 248 | 258 | 383 | 468 | 505 | 542 | 558 | 580 | 561 | 564 | 425 | 416 | 412 | 433 | 519 | 529 | 553 |
| Change (%) | 3.12 | 17.56 | 13.88 | 4.12 | 48.60 | 21.99 | 8.06 | 7.22 | 2.95 | 3.87 | -3.26 | 0.66 | -24.67 | -2.07 | -0.96 | 5.07 | 19.83 | 1.83 | 4.58 | |
| % of Revenue | 33.25 | 32.30 | 34.42 | 36.31 | 30.06 | 33.54 | 33.45 | 31.62 | 32.82 | 34.52 | 35.09 | 34.25 | 35.55 | 33.28 | 35.88 | 37.69 | 37.83 | 39.55 | 39.60 | 41.13 |
| SG&A | 348 | 397 | 387 | 394 | 446 | 452 | 524 | 604 | 607 | 596 | 602 | 602 | 609 | 458 | 430 | 391 | 395 | 454 | 459 | 466 |
| Change (%) | 14.24 | -2.44 | 1.68 | 13.28 | 1.30 | 16.07 | 15.21 | 0.48 | -1.80 | 0.91 | 0.10 | 1.15 | -24.77 | -6.28 | -8.87 | 0.82 | 15.18 | 1.01 | 1.46 | |
| % of Revenue | 64.36 | 69.28 | 61.27 | 57.71 | 51.97 | 39.53 | 37.51 | 37.81 | 36.77 | 36.90 | 36.43 | 36.79 | 38.38 | 35.87 | 37.02 | 35.78 | 34.46 | 34.63 | 34.39 | 34.66 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 704 | 781 | 799 | 757 | 961 | 1,102 | 1,330 | 1,620 | 1,629 | 1,645 | 1,678 | 1,703 | 1,682 | 1,302 | 1,166 | 1,062 | 1,090 | 1,238 | 1,254 | 1,249 |
| Change (%) | 11.00 | 2.33 | -5.23 | 26.92 | 14.61 | 20.75 | 21.78 | 0.55 | 0.96 | 2.01 | 1.48 | -1.22 | -22.59 | -10.47 | -8.85 | 2.61 | 13.51 | 1.34 | -0.39 | |
| % of Revenue | 130.32 | 136.30 | 126.44 | 110.99 | 112.00 | 96.37 | 95.14 | 101.37 | 98.66 | 101.77 | 101.58 | 104.01 | 105.97 | 101.92 | 100.47 | 97.13 | 95.21 | 94.29 | 93.95 | 92.95 |
| Operating Income | -164 | -208 | -167 | -75 | -103 | 42 | 68 | -22 | 22 | -29 | -26 | -66 | -95 | -24 | -6 | 31 | 55 | 75 | 81 | 95 |
| Change (%) | 27.06 | -19.66 | -55.12 | 37.33 | -140.29 | 63.86 | -132.21 | -201.37 | -228.83 | -8.74 | 151.34 | 44.36 | -74.13 | -77.55 | -670.91 | 74.52 | 36.86 | 7.73 | 17.33 | |
| % of Revenue | -30.32 | -36.30 | -26.44 | -10.99 | -12.00 | 3.63 | 4.86 | -1.37 | 1.34 | -1.77 | -1.58 | -4.01 | -5.97 | -1.92 | -0.47 | 2.87 | 4.79 | 5.71 | 6.05 | 7.05 |
| Interest Expense | -38 | -34 | -28 | -22 | -22 | -24 | -26 | -30 | -32 | -40 | -47 | -53 | -60 | -56 | -60 | -61 | -61 | -62 | -61 | -53 |
| Change (%) | -10.29 | -17.35 | -22.06 | -1.37 | 9.72 | 8.44 | 15.18 | 9.12 | 24.15 | 16.71 | 12.82 | 13.45 | -6.01 | 6.22 | 1.67 | -0.16 | 2.47 | -2.41 | -13.18 | |
| % of Revenue | -7.02 | -5.93 | -4.45 | -3.21 | -2.52 | -2.07 | -1.84 | -1.85 | -1.96 | -2.48 | -2.83 | -3.23 | -3.77 | -4.41 | -5.15 | -5.56 | -5.30 | -4.74 | -4.55 | -3.92 |
| Net Income | -217 | -293 | -255 | -160 | -91 | 64 | 90 | 21 | -28 | -29 | -34 | -80 | -123 | -99 | -94 | -56 | -23 | 45 | 184 | 204 |
| Change (%) | 35.24 | -13.17 | -37.12 | -43.04 | -170.61 | 39.44 | -76.84 | -236.54 | 3.52 | 14.97 | 136.09 | 54.39 | -19.56 | -4.84 | -40.19 | -59.22 | -293.91 | 311.66 | 11.06 | |
| % of Revenue | -40.16 | -51.17 | -40.28 | -23.46 | -10.63 | 5.63 | 6.42 | 1.30 | -1.72 | -1.82 | -2.05 | -4.87 | -7.76 | -7.76 | -8.13 | -5.16 | -2.01 | 3.40 | 13.75 | 15.17 |
Source: Capital IQ
